Opus Point Partners Management’s Checkpoint Therapeutics CKPT Stock Holding History

Opus Point Partners Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$281K	Hold	11,276	–	–	0.51%	42
2019 Q2	$342K	Hold	11,276	–	–	0.51%	47
2019 Q1	$322K	Hold	11,276	–	–	0.44%	57
2018 Q4	$205K	Hold	11,276	–	–	0.45%	37
2018 Q3	$404K	Hold	11,276	–	–	0.96%	33
2018 Q2	$336K	Hold	11,276	–	–	0.73%	32
2018 Q1	$495K	Hold	11,276	–	–	0.97%	28
2017 Q4	$438K	Hold	11,276	–	–	0.38%	40
2017 Q3	$507K	Sell	11,276 -500	-4%	-$43.4K	0.45%	51
2017 Q2	$530K	Buy	+11,776	New	+$1.16M	0.49%	45

Other funds holding CKPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

PAS

Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

Opus Point Partners Management's CKPT Position: Q3 2019 in Review

Opus Point Partners Management held its Checkpoint Therapeutics (CKPT) position steady in Q3 2019 at 11,276 shares worth $281K. The position accounts for 0.51% of the portfolio, ranked #42.

Opus Point Partners Management first reported a position in CKPT in Q2 2017 and has held it in 10 quarters since. The position peaked at $530K in Q2 2017. 37 funds tracked by Wall St. Rank hold CKPT as of Q3 2019.

Opus Point Partners Management held 11,276 shares of Checkpoint Therapeutics worth $281K as of Q3 2019.
Opus Point Partners Management left its Checkpoint Therapeutics share count unchanged in Q3 2019.
Checkpoint Therapeutics made up 0.51% of Opus Point Partners Management's portfolio in Q3 2019, its #42 holding.
Opus Point Partners Management first reported a position in Checkpoint Therapeutics in Q2 2017 and has held it in 10 quarters since.
Opus Point Partners Management's Checkpoint Therapeutics position peaked at $530K in Q2 2017.
37 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.